Douglas W. Blayney
Academic Appointments
- Professor - Med Center Line, Medicine - Oncology
- Member, Stanford Cancer Institute
Key Documents
Contact Information
-
Clinical Offices
Stanford Women�s Cancer Center 900 Blake Wilbur Stanford, CA 94305 Tel Work (650) 498-6004 Fax (650) 490-7237
- Academic Offices
Personal Information Email Tel (650) 725-6704Alternate Contact Martha Pena Email Tel Work 650 725 6704Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Breast Cancer
- Medical Oncology
- Cancer Survivorship
- Breast cancer
Administrative Appointments
- Medical Director, Stanford Cancer Center (2010 - present)
- Medical Director, University of Michigan Comprehensive Cancer Center (2003 - 2010)
- President, Wilshire Oncology Medical Group, Inc. (1996 - 2003)
Honors and Awards
- President, American Society of Clinical Oncology (2009-10)
Professional Education
| Residency: | UCSD School of Medicine, CA USA (06/1980) |
| Medical Education: | UC San Diego School of Medicine CA (06/1977) |
| Fellowship: | National Cancer Institute - Center Cancer Research MD (08/1983) |
| Board Certification: | Medical Oncology, American Board of Internal Medicine (1983) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (1980) |
| Fellowship: | Medicine Branch, National Cancer Institute, Bethesda, Maryland (1983) |
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industrial and other commercial partners. It is our policy to disclose payments (exclusive of travel support) from, and/or equity in, companies or other commercial entities to Stanford faculty of $5,000 or more in total value, as well as any equity in a privately held company, when the faculty member also has institutional responsibilities related to his or her interactions with the company. View Full Information
Scientific Focus
Current Research Interests
Use of medical informatics to improve quality delivery in cancer care
Publications
- Measuring the improving quality of outpatient care in medical oncology practices in the United States. J Clin Oncol. 2013; (11): 1471-7
- Tumor boards (team huddles) aren't enough to reach the goal. J Natl Cancer Inst. 2013; (2): 82-4
- Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer. J Clin Oncol. 2012; (18): 2218-26
- American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology. J Clin Oncol. 2012; (14): 1715-24
- Michigan oncology practices showed varying adherence rates to practice guidelines, but quality interventions improved care. Health Aff (Millwood). 2012; (4): 718-28
- Enhancing quality through innovation: American Society of Clinical Oncology presidential address 2010. J Clin Oncol. 2010; (28): 4283-8
Help
Trial Administration